Back to PRLD
MORGAN STANLEY PRLD Position History
Prelude Therapeutics Incorporated • Healthcare
Quarters held
60
Latest value
$712K
Q3 2026
Peak value
$1.5M
First seen
Q2 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2024 | $465 |
| Q2 2024 | $925K |
| Q2 2024 | $583 |
| Q2 2024 | $47K |
| Q2 2024 | $116K |
| Q2 2024 | $5K |
| Q2 2024 | $4 |
| Q2 2024 | $2K |
| Q3 2024 | $543K |
| Q3 2024 | $184 |
| Q3 2024 | $72K |
| Q3 2024 | $52K |
| Q3 2024 | $3K |
| Q3 2024 | $2 |
| Q3 2024 | $855 |
| Q4 2024 | $341K |
| Q4 2024 | $92K |
| Q4 2024 | $32K |
| Q4 2024 | $1 |
| Q1 2025 | $202K |
| Q1 2025 | $55 |
| Q1 2025 | $12K |
| Q1 2025 | $19K |
| Q1 2025 | $1 |
| Q2 2025 | $209K |
| Q2 2025 | $2K |
| Q2 2025 | $20K |
| Q2 2025 | $1 |
| Q3 2025 | $374K |
| Q3 2025 | $305 |
| Q3 2025 | $35K |
| Q3 2025 | $1 |
| Q3 2025 | $374K |
| Q3 2025 | $305 |
| Q3 2025 | $35K |
| Q3 2025 | $1 |
| Q4 2025 | $801K |
| Q4 2025 | $106K |
| Q4 2025 | $64K |
| Q4 2025 | $3 |
| Q4 2025 | $801K |
| Q4 2025 | $106K |
| Q4 2025 | $64K |
| Q4 2025 | $3 |
| Q1 2026 | $949K |
| Q1 2026 | $50K |
| Q1 2026 | $102K |
| Q1 2026 | $3 |
| Q2 2026 | $1.5M |
| Q2 2026 | $155 |
| Q2 2026 | $99K |
| Q2 2026 | $133K |
| Q2 2026 | $5 |
| Q2 2026 | $971K |
| Q3 2026 | $1.2M |
| Q3 2026 | $500 |
| Q3 2026 | $49K |
| Q3 2026 | $97K |
| Q3 2026 | $8K |
| Q3 2026 | $712K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $712K | 182.1K | — | — |
| Q3 2026 | $8K | 2.0K | — | — |
| Q3 2026 | $97K | 24.8K | — | — |
| Q3 2026 | $49K | 12.6K | — | — |
| Q3 2026 | $500 | 128 | — | — |
| Q3 2026 | $1.2M | 298.4K | — | — |
| Q2 2026 | $971K | 182.1K | — | — |
| Q2 2026 | $5 | 1 | — | — |
| Q2 2026 | $133K | 24.9K | — | — |
| Q2 2026 | $99K | 18.6K | — | — |
| Q2 2026 | $155 | 29 | — | — |
| Q2 2026 | $1.5M | 278.2K | — | — |
| Q1 2026 | $3 | 1 | — | — |
| Q1 2026 | $102K | 29.9K | — | — |
| Q1 2026 | $50K | 14.7K | — | — |
| Q1 2026 | $949K | 277.5K | — | — |
| Q4 2025 | $3 | 1 | — | — |
| Q4 2025 | $64K | 22.1K | — | — |
| Q4 2025 | $106K | 36.6K | — | — |
| Q4 2025 | $801K | 276.1K | — | — |
| Q4 2025 | $3 | 1 | — | — |
| Q4 2025 | $64K | 22.1K | — | — |
| Q4 2025 | $106K | 36.6K | — | — |
| Q4 2025 | $801K | 276.1K | — | — |
| Q3 2025 | $1 | 1 | — | — |
| Q3 2025 | $35K | 24.3K | — | — |
| Q3 2025 | $305 | 212 | — | — |
| Q3 2025 | $374K | 259.7K | — | — |
| Q3 2025 | $1 | 1 | — | — |
| Q3 2025 | $35K | 24.3K | — | — |
| Q3 2025 | $305 | 212 | — | — |
| Q3 2025 | $374K | 259.7K | — | — |
| Q2 2025 | $1 | 1 | — | — |
| Q2 2025 | $20K | 24.5K | — | — |
| Q2 2025 | $2K | 2.2K | — | — |
| Q2 2025 | $209K | 257.7K | — | — |
| Q1 2025 | $1 | 1 | — | — |
| Q1 2025 | $19K | 24.9K | — | — |
| Q1 2025 | $12K | 15.4K | — | — |
| Q1 2025 | $55 | 71 | — | — |
| Q1 2025 | $202K | 262.4K | — | — |
| Q4 2024 | $1 | 1 | — | — |
| Q4 2024 | $32K | 25.5K | — | — |
| Q4 2024 | $92K | 72.1K | — | — |
| Q4 2024 | $341K | 267.6K | — | — |
| Q3 2024 | $855 | 413 | — | — |
| Q3 2024 | $2 | 1 | — | — |
| Q3 2024 | $3K | 1.3K | — | — |
| Q3 2024 | $52K | 25.2K | — | — |
| Q3 2024 | $72K | 34.6K | — | — |
| Q3 2024 | $184 | 89 | — | — |
| Q3 2024 | $543K | 262.1K | — | — |
| Q2 2024 | $2K | 502 | — | — |
| Q2 2024 | $4 | 1 | — | — |
| Q2 2024 | $5K | 1.3K | — | — |
| Q2 2024 | $116K | 30.3K | — | — |
| Q2 2024 | $47K | 12.2K | — | — |
| Q2 2024 | $583 | 153 | — | — |
| Q2 2024 | $925K | 242.7K | — | — |
| Q2 2024 | $465 | 122 | — | — |
Other funds holding PRLD
$73.2M
$53.7M
$39.6M
$37.3M
$34.6M
$31.6M